Barings BDC, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US06759L1035
USD
8.78
0.05 (0.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Barings BDC, Inc. stock-summary
stock-summary
Barings BDC, Inc.
Capital Markets
Barings BDC, Inc is a closed-end, non-diversified investment company. The Company’s investment objective is to generate income by investing directly in privately held middle-market companies to help companies fund acquisitions, growth or refinancing. The Company focuses on investments in companies with a history of generating revenues, an established market position and a proven management team with operating discipline. The Company invests in senior and subordinated debt securities of privately held companies, generally secured by security interests in portfolio company assets. The Company invests in one or more equity instruments of the borrower. The Company’s investments generally ranged from $5.0 million to $50.0 million per portfolio company. The Company’s investment adviser is Massachusetts Mutual Life Insurance Company.
Company Coordinates stock-summary
Company Details
300 S Tryon St Ste 2500 , CHARLOTTE NC : 28202-3393
stock-summary
Tel: 1 704 8057200
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 17 Schemes (7.54%)

Foreign Institutions

Held by 42 Foreign Institutions (4.62%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Michael Freno
Chairman of the Board
Mr. Eric Lloyd
Chief Executive Officer, Director
Mr. Robert Knapp
Director
Mr. David Mihalick
Director
Mr. Mark Mulhern
Independent Director
Mr. Thomas Okel
Independent Director
Ms. Jill Olmstead
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
58 Million
(Quarterly Results - Jun 2025)
Net Profit:
21 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 993 Million (Small Cap)

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

12.70%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

8.50%

stock-summary
Price to Book

0.84